title: [High deposition rate of aluminum in tissues in diabetic hemodialysis patients].
abstract: Aluminum (Al) accumulation in bone is a serious problem in patients on hemodialysis. We studied deferoxamine infusion test (DFO test) in 14 diabetic patients on hemodialysis (HDDM) and 23 hemodialysis patients originated from glomerulo nephritis (HDCGN) to determine whether Al accumulation is different between the two groups or not. There was no difference in hemodialysis duration and total oral intake of Al containing drugs between two groups. Serum C-terminal parathyroid hormone (C-PTH) in HDDM was lower than that in HDCGN group (1.82 +/- 1.30 vs. 3.80 +/- 1.82 ng/ml; P less than 0.01). However serum Al (s-Al) levels were comparable (61.9 +/- 53.0 vs, 45.0 +/- 32.3 micrograms/l). A significant correlation was observed between duration of dialysis period and s-Al in HDDM (r = 0.806, p less than 0.01), but in HDCGN, the relation was not significant. The patients in HDDM whose cumulative aluminum intake was less than 2.0 kg showed the higher serum A1 concentrations before DFO and greater increases in s-Al after DFO test, as compared with those in HDCGN with matched aluminum intake (93.8 +/- 67.6 vs. 35.9 +/- 23.6 micrograms/l; p less than 0.001 and 141.2 +/- 81.8 vs. 70.3 +/- 41.1 micrograms/l; p = 0.035). These results indicate that in uremic diabetic patients with lower intake of Al containing drugs, an early accumulation of Al in the whole body occurs possibly because of the enhanced absorption rate of Al at an intestine and/or the low PTH level.
authors.affiliation: Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama.
authors.forename: S
authors.initials: S
authors.lastname: Iwasaki
authors.forename: T
authors.initials: T
authors.lastname: Ideura
authors.forename: A
authors.initials: A
authors.lastname: Yoshimura
authors.forename: M
authors.initials: M
authors.lastname: Chimata
authors.forename: M
authors.initials: M
authors.lastname: Kawamura
authors.forename: M
authors.initials: M
authors.lastname: Sudo
authors.forename: S
authors.initials: S
authors.lastname: Koshikawa
mesh_terms: D000328:Adult; D000368:Aged; D000535:Aluminum / Q000493:pharmacokinetics*; D003676:Deferoxamine; D003928:Diabetic Nephropathies / Q000378:metabolism* / Q000628:therapy; D005260:Female; D005921:Glomerulonephritis / Q000378:metabolism / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014018:Tissue Distribution
chemical_list: D000535:Aluminum; D003676:Deferoxamine